Meghan Naas
About Meghan Naas
Meghan Naas is a Senior Director of Corporate Compliance at Adaptimmune, with extensive experience in compliance and risk management across the pharmaceutical and financial sectors. She has held various leadership roles, including Director of Compliance at TESARO and Senior Director at Zai Lab, and has a strong academic background in English and Economics from Boston College and the College of the Holy Cross.
Current Role at Adaptimmune
Meghan Naas serves as the Senior Director of Corporate Compliance at Adaptimmune, a position she has held since 2024. In this role, she is responsible for overseeing compliance initiatives within the organization, ensuring adherence to regulatory standards and internal policies. Adaptimmune is located in Cambridge, Massachusetts, and operates in a hybrid work environment.
Previous Experience in Compliance and Risk Management
Prior to her current position, Meghan Naas held various roles in compliance and risk management across multiple organizations. She worked at Zai Lab as Senior Director of Global Operations and US Compliance Officer from 2021 to 2024. Before that, she was the Associate Director of Compliance at TESARO, Inc. from 2015 to 2019. Her experience includes developing policies and procedures for compliance in the pharmaceutical industry.
Career Background in Financial Services
Meghan Naas began her career in the financial sector, where she held several positions at Investors Bank & Trust (now part of State Street). Her roles included Global Custody Operations Senior Representative, Senior Internal Auditor, and Institutional Custody Project Unit Manager. She also served as the Director of Compliance/Risk and Special Projects at Shepherd Kaplan LLC from 2007 to 2014.
Educational Qualifications
Meghan Naas holds a Master's degree in English Language and Literature from Boston College, which she completed from 2003 to 2007. She also earned a Bachelor's degree in Economics and English from the College of the Holy Cross, where she studied from 1997 to 2001. Her educational background supports her expertise in compliance and risk management.
Expertise in Pharmaceutical Compliance
Meghan Naas has established the Global Operations function at multiple pharmaceutical companies. She has implemented Anti-Bribery/Corruption, Transparency, Training, and Monitoring Programs. Her role as an experienced business partner to Medical and Commercial colleagues highlights her ability to navigate complex compliance landscapes in the pharmaceutical industry.